Menu
Back to User profile » Dr Ningning Tao
Papers published by Dr Ningning Tao:
Trends in the Notification Rates and Treatment Outcome of Tuberculosis in Shandong Province, China, 2005–2021
Han Q, Li Y, Liu Y, Zhu X, An Q, Li Y, Wang T, Zhang Y, Li Y, Fang W, Tao N, Li H
Infection and Drug Resistance 2024, 17:1477-1490
Published Date: 12 April 2024
Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway
Liu J, Fan G, Tao N, Feng F, Meng C, Sun T
Drug Design, Development and Therapy 2022, 16:1793-1809
Published Date: 13 June 2022
Role of Pyroptosis in Respiratory Diseases and its Therapeutic Potential
Liu J, Fan G, Tao N, Sun T
Journal of Inflammation Research 2022, 15:2033-2050
Published Date: 28 March 2022
Primary Drug-Resistance Pattern and Trend in Elderly Tuberculosis Patients in Shandong, China, from 2004 to 2019
An Q, Song W, Liu J, Tao N, Liu Y, Zhang Q, Xu T, Li S, Liu SQ, Li Y, Yu C, Li H
Infection and Drug Resistance 2020, 13:4133-4145
Published Date: 13 November 2020
Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China
Song W, Shao Y, Liu J, Tao N, Liu Y, Zhang Q, Xu T, Li S, Yu CB, Gao L, Cui L, Li Y, Li H
Infection and Drug Resistance 2019, 12:2397-2407
Published Date: 2 August 2019